Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM)

Richard D. Carvajal; Jeffrey Alan Sosman; Fernando Quevedo; Mohammed M. Milhem; Anthony Michael Joshua; Ragini Reiney Kudchadkar; Gerald P. Linette; Thomas Gajewski; Jose Lutzky; David H. Lawson; Christopher D. Lao; Patrick J. Flynn; Mark R. Albertini; Takami Sato; Daniel Paucar; Katherine S. Panageas; Mark Andrew Dickson; Jedd D. Wolchok; Paul B. Chapman; Gary K. Schwartz

doi:10.1200/jco.2013.31.15_suppl.cra9003

Back

Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM)

Abstract

Peer reviewed

Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM)

Richard D. Carvajal, Jeffrey Alan Sosman, Fernando Quevedo, Mohammed M. Milhem, Anthony Michael Joshua, Ragini Reiney Kudchadkar, Gerald P. Linette, Thomas Gajewski, Jose Lutzky, David H. Lawson, …

Journal of clinical oncology, Vol.31(15_suppl), pp.CRA9003-CRA9003

05/20/2013

DOI: 10.1200/jco.2013.31.15_suppl.cra9003

View Online

Abstract

CRA9003 The full, final text of this abstract will be available at abstract.asco.org at 7:30 AM (EDT) on Saturday, June, 1, 2013, and in the Annual Meeting Proceedings online supplement to the June 20, 2013, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Saturday edition of ASCO Daily News.

Details

Title: Subtitle: Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM)
Creators: Richard D. Carvajal - Memorial Sloan Kettering Cancer Center
Jeffrey Alan Sosman - Vanderbilt University Medical Center
Fernando Quevedo - Mayo Clinic, Rochester, MN
Mohammed M. Milhem - University of Iowa
Anthony Michael Joshua - Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
Ragini Reiney Kudchadkar - Moffitt Cancer Center
Gerald P. Linette - Washington University in St. Louis
Thomas Gajewski - University of Chicago
Jose Lutzky - Mount Saint Vincent University
David H. Lawson - Emory University School of Medicine
Christopher D. Lao - University of Michigan–Ann Arbor
Patrick J. Flynn - Metro-Minnesota Community Oncology Research Consortium
Mark R. Albertini - University of Wisconsin–Madison
Takami Sato - Thomas Jefferson University
Daniel Paucar - Memorial Sloan Kettering Cancer Center
Katherine S. Panageas - Memorial Sloan Kettering Cancer Center
Mark Andrew Dickson - Memorial Sloan Kettering Cancer Center
Jedd D. Wolchok - Memorial Sloan Kettering Cancer Center
Paul B. Chapman - Memorial Sloan Kettering Cancer Center
Gary K. Schwartz - Memorial Sloan Kettering Cancer Center
Resource Type: Abstract
Publication Details: Journal of clinical oncology, Vol.31(15_suppl), pp.CRA9003-CRA9003
DOI: 10.1200/jco.2013.31.15_suppl.cra9003
ISSN: 0732-183X
eISSN: 1527-7755
Language: English
Date published: 05/20/2013
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
Record Identifier: 9984363183602771

Metrics

10 Record Views